NeueHealth, Inc. Common Stock (NEUE)

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NeueHealth, Inc. (NYSENEUE) to an affiliate of New Enterprise Associates. Under the terms of the proposed transaction, shareholders of NeueHealth will receive $7.33 in cash for each share of NeueHealth that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

BALA CYNWYD, Pa., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, Dec. 28, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. (“NeueHealth” or “the Company”) (NYSENEUE) for potential breaches of fiduciary duty on the part of its directors and management.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of NeueHealth, Inc. (NYSENEUE) to an affiliate of New Enterprise Associates for $7.33 per share in cash is fair to NeueHealth shareholders.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates (“NEA”) at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its value-driven, consumer-centric care model.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today reported financial results for its third quarter ended September 30, 2024.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that Centrum Health, one of the Company’s value-driven clinic brands, became a wholly owned subsidiary through the Company’s acquisition of the remaining 25% equity interest of the business that it did not already own. This action simplifies NeueHealth’s corporate structure, streamlining operations to support its ongoing focus on advancing its value-driven, consumer-centric care model.

NeueHealth, Inc. ("NeueHealth") (NYSENEUE), the value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Thursday, November 7, 2024, followed by a conference call at 8:00 AM Eastern Time.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2024.

NeueHealth, Inc. ("NeueHealth") (NYSENEUE), the value-driven healthcare company, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 7, 2024, followed by a conference call at 8:00 AM Eastern Time.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that it entered into a secured loan facility for up to $150 million with Hercules Capital, Inc. NYSE: HTGCNYSEHTGC)

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that on June 12, 2024, the Company received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company no longer satisfies the continued listing standards set forth under Section 802.01B of the NYSE’s Listed Company Manual. The notice cited that the Company’s average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company’s last reported stockholders’ equity was less than $50 million. As of June 11, 2024, the 30 trading-day average market capitalization was approximately $49.7 million, and the company reported a stockholders’ deficit. The Company’s preferred stock, which had a value of $920.4 million as of March 31, 2024, is excluded from the average market capitalization as calculated by the NYSE. This notice does not impact the Company’s business operations.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today reported financial results for its First Quarter ended March 31, 2024.

NeueHealth, Inc. ("NeueHealth") (NYSENEUE), the value-driven healthcare company, today announced it will report First Quarter financial results before the financial markets open on Wednesday, May 8, 2024, followed by a conference call at 8:00 AM Eastern Time.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today announced that it entered into an incremental amendment to its credit facility with New Enterprise Associates (“NEA”) that increases the term loan commitment by $30 million on April 8, 2024. The proceeds of the incremental commitment are intended to be used for general corporate purposes, including to support the Company’s 2024 strategic priorities.

NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSENEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2023.

NeueHealth, Inc. ("NeueHealth") (NYSENEUE), the value-driven healthcare company, today announced it will report Fourth Quarter financial results before the financial markets open on Wednesday, March 6, 2024, followed by a conference call at 8:00 AM Eastern Time.

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Bright Health Group, Inc. (NYSEBHG) on behalf of long-term stockholders following a class action complaint that was filed against Bright Health on January 6, 2022 with a Class Period from June 21, 2021 to March 1, 2022. Our investigation concerns whether the board of directors of Bright Health have breached their fiduciary duties to the company.